TGM2 and breast carcinoma: These results indicate that repeated injection of Tg2-rich wildtype MV- during the growth of MDA- (shTg2) primary tumors resulted in primary tumor stiffening, increased fibroblast activation, and increased metastasis of the Tg2-knockdown weakly migratory breast cancer subpopulation.